MedPath

Nanfang Hospital Southern Medical University

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease

Phase 2
Conditions
Chronic Graft-versus-host Disease
Interventions
Biological: Non-mesenchymal stem cells
Biological: Mesenchymal stem cells
First Posted Date
2013-01-10
Last Posted Date
2013-01-10
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
60
Registration Number
NCT01765660
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease

Phase 2
Conditions
Acute Graft-versus-host Disease
Interventions
Biological: Mesenchymal stem cells
Biological: Non-mesenchymal stem cells
First Posted Date
2013-01-10
Last Posted Date
2013-01-10
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
40
Registration Number
NCT01765634
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure

Phase 2
Conditions
Hematopoietic Stem Cell Transplantation
Mesenchymal Stem Cells
Umbilical Cord Blood
Graft Failure
Hematological Diseases
Interventions
Biological: Mesenchymal stem cells
Biological: Mesenchymal stem cells and cord blood
First Posted Date
2013-01-08
Last Posted Date
2013-01-16
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
60
Registration Number
NCT01763099
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplant

Phase 2
Conditions
Stem Cell Transplantation, Hematopoietic
Mesenchymal Stem Cells
Poor Graft Function
Hematological Diseases
Interventions
Biological: Mesenchymal stem cells
First Posted Date
2013-01-08
Last Posted Date
2013-01-16
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
60
Registration Number
NCT01763086
Locations
🇨🇳

Department of Hematology,Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China

Multicenter Study on Laparoscopic Distal Subtotal Gastrectomy for Advanced Gastric Cancer (CLASS-01)

Phase 3
Conditions
Stomach Neoplasms
Interventions
Procedure: Laparoscopic gastrectomy
Procedure: Open gastrectomy
First Posted Date
2012-05-31
Last Posted Date
2015-01-27
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
1056
Registration Number
NCT01609309
Locations
🇨🇳

Peking University Cancer Hospital, Beijing, Beijing, China

🇨🇳

The People's Liberation Army General Hospital, Beijing, Beijing, China

🇨🇳

Fujian Medical University Union Hospital, Fuzhou, Fujian, China

and more 11 locations

EFFORT Extension Study

Phase 4
Conditions
Hepatitis B, Chronic
Interventions
First Posted Date
2012-02-08
Last Posted Date
2014-06-19
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
576
Registration Number
NCT01529255
Locations
🇨🇳

Beijing Ditan Hospita, Beijing, Beijing, China

🇨🇳

Beijing Friendship Hospital Attached To The Capital Medical University, Beijing, Beijing, China

🇨🇳

BeiJing YouAn Hospital ,Capital Medical University, Beijing, Beijing, China

and more 21 locations

Intensified Conditioning Regimen With High-Dose-Etoposide for Allo-HSCT for Adult Acute Lymphoblastic Leukemia

Phase 2
Completed
Conditions
Acute Lymphoblastic Leukemia
Stem Cell Transplantation, Hematopoietic
Interventions
Drug: TBI+CY+VP-16
Drug: FA+TBI+CY+VP-16
First Posted Date
2011-10-21
Last Posted Date
2017-10-12
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
200
Registration Number
NCT01457040
Locations
🇨🇳

Department of Hematology, Nanfang Hospital, Guangzhou, Guangdong, China

Efficacy and Safety of rHuTPO on Platelet Engraftment After Allo-HSCT

Phase 4
Conditions
Allogeneic Hematopoietic Stem Cell Transplantation
Myeloablative
Delayed Platelet Engraftment
Interventions
First Posted Date
2011-06-23
Last Posted Date
2015-10-09
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
80
Registration Number
NCT01379391
Locations
🇨🇳

Guangzhou General Hospital of Guangzhou Military Command, Guangzhou, Guangdong, China

🇨🇳

Zhongshan People Hospital,Guangdong, Zhongshan, Guangdong, China

🇨🇳

Guangdong No.2 Provincial People's Hospital, Guangzhou, Guangdong, China

and more 6 locations

Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B

Phase 3
Conditions
Chronic Hepatitis B
Interventions
Device: medical ozone therapy with tianyi
Device: medical ozone therapy with humares
First Posted Date
2011-04-27
Last Posted Date
2012-10-18
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
189
Registration Number
NCT01342185
Locations
🇨🇳

Nanfang Hospital, GuangZhou, Guangdong, China

Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC Therapy

Phase 4
Conditions
Hepatitis B
Interventions
First Posted Date
2011-04-26
Last Posted Date
2013-10-30
Lead Sponsor
Nanfang Hospital, Southern Medical University
Target Recruit Count
360
Registration Number
NCT01341743
Locations
🇨🇳

Shanghai Ruijin Hospital, ShangHai, Shanghai, China

🇨🇳

First Hospital .Jilin Unniversity, ChangChun, Jilin, China

🇨🇳

Changhai Hospital affiliated to Second Military Medical University, ShangHai, Shanghai, China

and more 13 locations
© Copyright 2025. All Rights Reserved by MedPath